TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche

Authors

Juo-Chin Yao, Washington University School of Medicine in St. Louis
Karolyn A. Oetjen, Washington University School of Medicine in St. Louis
Tianjiao Wang, Washington University School of Medicine in St. Louis
Haoliang Xu, Washington University School of Medicine in St. Louis
Grazia Abou-Ezzi, Washington University School of Medicine in St. Louis
Joseph R. Krambs, Washington University School of Medicine in St. Louis
Salil Uttarwar, Washington University School of Medicine in St. Louis
Eric J. Duncavage, Washington University School of Medicine in St. Louis
Daniel C. Link, Washington University School of Medicine in St. Louis

Journal

Journal of Clinical Investigation

Publication Date

6-1-2022

Volume

132

Issue

11

First Page

e154092

Document Type

Open Access Publication

DOI

10.1172/JCI154092

Rights and Permissions

Yao JC, Oetjen KA, Wang T, Xu H, Abou-Ezzi G, Krambs JR, Uttarwar S, Duncavage EJ, Link DC. TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche. J Clin Invest. 2022 Jun 1;132(11):e154092. doi.org/10.1172/JCI154092. Copyright: © 2022, Yao et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.

Recommended Citation

Yao, Juo-Chin; Oetjen, Karolyn A.; Wang, Tianjiao; Xu, Haoliang; Abou-Ezzi, Grazia; Krambs, Joseph R.; Uttarwar, Salil; Duncavage, Eric J.; and Link, Daniel C., "TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche." Journal of Clinical Investigation. 132, 11. e154092 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11985